Previous Close | 27.71 |
Open | 27.52 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 27.32 - 28.42 |
52 Week Range | 22.01 - 32.88 |
Volume | |
Avg. Volume | 1,718,781 |
Market Cap | 4.627B |
Beta (5Y Monthly) | 0.42 |
PE Ratio (TTM) | 12.32 |
EPS (TTM) | 2.28 |
Earnings Date | Oct 24, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 34.92 |
BioMarin (BMRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Besides Wall Street's top -and-bottom-line estimates for Alkermes (ALKS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.